Location History:
- Osaka, JP (2021)
- Suita, JP (2021)
Company Filing History:
3 out of 989 
1 out of 45 
1 out of 35 Years Active: 2021
Title: Kiyohito Yagi: Innovator in Monoclonal Antibody Research
Introduction
Kiyohito Yagi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of monoclonal antibodies, with a focus on Claudin proteins. His innovative work has led to the development of several important patents.
Latest Patents
Kiyohito Yagi holds 3 patents. His latest patents include an anti-claudin-2 monoclonal antibody, which aims to provide a monoclonal antibody that recognizes an extracellular region of Claudin-2. Additionally, he has developed an anti-CLDN-5 antibody and a drug containing said antibody, which offers high specificity to CLDN-5 and recognizes an extracellular domain of the protein.
Career Highlights
Throughout his career, Kiyohito Yagi has worked with esteemed institutions such as Osaka University and Ehime University. His research has significantly advanced the understanding of Claudin proteins and their applications in medicine.
Collaborations
Kiyohito Yagi has collaborated with notable colleagues, including Masuo Kondoh and Takefumi Doi. Their joint efforts have contributed to the success of various research projects and innovations in the field.
Conclusion
Kiyohito Yagi's work in monoclonal antibody research exemplifies the impact of innovative thinking in the medical field. His patents and collaborations continue to influence advancements in therapeutic applications.